this was a randomized, placebo-controlled, two-period, blinded study in 40 hcv genotype 1-infected patients (na?ve and treatment-experienced).
该研究是一项在40例hcv基因型1感染患者(初治和复治)中进行的随机、安慰剂对照、二期、盲性研究。
patients received study medication through week 30 and could continue in a blinded study extension through week 50.
病人接受研究药物治疗30周,并可继续留在盲法扩展研究中直至50周。
methods: single blinded study was conducted in 38 aged ma le with kds, who were randomly divided into 2 groups treated with wzyzp and placebo respectively for 3 months.
方法:38例男性老年肾虚者采用单盲法,随机分为五子衍宗丸治疗组和安慰剂对照组,服药3个月。